Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China · Delayed Price · Currency is CNY 14.25
-0.19 (-1.32%)
Apr 8, 2026, 3:04 PM CST
SHE:002675 Revenue
In the year 2025, Yantai Dongcheng Pharmaceutical Group had annual revenue of 2.74B CNY, down -4.46%. Yantai Dongcheng Pharmaceutical Group had revenue of 697.99M in the quarter ending December 31, 2025, a decrease of -1.21%.
Revenue
2.74B
Revenue Growth
-4.46%
P/S Ratio
4.29
Revenue / Employee
1.06M
Employees
2,583
Market Cap
11.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.74B | -127.86M | -4.46% |
| Dec 31, 2024 | 2.87B | -406.71M | -12.42% |
| Dec 31, 2023 | 3.28B | -307.31M | -8.58% |
| Jan 1, 2023 | 3.58B | -329.09M | -8.41% |
| Jan 1, 2022 | 3.91B | 493.07M | 14.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisun Pharmaceutical | 10.55B |
| Zhejiang CONBA Pharmaceutical | 6.58B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 5.49B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Mayinglong Pharmaceutical Group | 3.77B |
| Porton Pharma Solutions | 3.42B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |